Search

everythinglearnresearchcommunity

for

Search:↓

The treatment increased hair follicle counts and is potentially effective for male hair loss without serious side effects.

Cyproterone acetate temporarily reduces hair growth in women with idiopathic hirsutism but doesn't change hormone levels.

Low SHBG and high FAI, FT, and DHEAS levels are effective in identifying PCOS.

Starting 5-alpha reductase inhibitors does not significantly increase the risk of rhabdomyolysis in older men, but is linked to a higher risk of muscle conditions.

New steroid compounds may help with hormonal therapy and have potential benefits for glucose disorders, but more research is needed.

CB-03-04 shows promise as a treatment for prostate issues due to its strong anti-androgen effects.

Hair analysis shows low progesterone in anorexia patients, unchanged by short-term weight gain.

Leonuri Herba alkaloids may help treat hormone-induced enlarged prostate in rats.

Cyproterone acetate with estradiol improved women's self-confidence and emotional well-being without a difference between oral or transdermal methods, but younger women preferred the oral method.

New treatments for prostate cancer and BPH show promise, including novel compounds that target hormone synthesis and response.

11α-Hydroxyprogesterone is changed into different substances by certain enzymes and may play a role in prostate cancer.

Gender-affirming hormone treatments need better patient-focused outcome measurements and standardized data collection.

Some new progesterone derivatives are better at blocking testosterone conversion than a common drug.

Dihydrotestosterone increases the activity of an enzyme in pubic skin cells that converts testosterone to dihydrotestosterone.

Blocking the enzyme that turns testosterone into DHT can safely and effectively treat enlarged prostate.

Antiandrogens and androgen inhibitors like spironolactone, finasteride, and dutasteride can treat hair loss and skin conditions, but they have risks and side effects, including potential harm to pregnant women and risks of cancer and heart issues. Herbal remedies also have antiandrogenic effects but lack safety validation.

Finasteride helps reduce hidradenitis suppurativa symptoms in females.

Hormone therapy for excessive hair growth is as good with GnRHa as with high-dose CPA, but GnRHa has longer-lasting results.

Compounds 4, 4b, and 4c effectively inhibit an enzyme linked to testosterone conversion without significant toxicity.

Women with excessive body hair often have higher male hormones and related health issues.

Finasteride and dutasteride are effective in treating male hair loss but can cause sexual side effects and birth defects.

Testosterone therapy seems safe for short-term use in postmenopausal women with low sexual desire, but more research on long-term effects is needed.

Using LC-MS/MS for hormone measurement can prevent false high testosterone results and avoid unnecessary tests.

5 alpha-reductase inhibitors can slightly improve symptoms of enlarged prostate but have a high risk of sexual side effects.

The study developed a method to detect minoxidil and its sulfate form, found that minoxidil sulfate is temperature-sensitive, and identified a way to potentially increase its stability for hair loss treatment.

Five new mutations in the androgen receptor gene were found, helping to understand androgen insensitivity syndrome better.

Modified steroidal inhibitors showed promise in treating hormone-dependent cancers.

5ARI treatment improves PSA test accuracy for prostate cancer diagnosis.

Using two drugs together, Flutamide and 4-MA, is more effective for blocking male hormones than using each one alone.

The questionnaire effectively measures men's perceived hair growth and can distinguish between different treatments and dosages.